Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Filed with BSE · · 3 pages · English
Sudarshan Pharma Industries Ltd on 6ix
Earlier from Sudarshan Pharma Industries
- Sudarshan Pharma Industries Ltd Press Release Mar 30 2026
- Closure of Trading Window
- Sudarshan Pharma Industries Ltd Press Release Feb 26 2026
- Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Updates On GST Inspection, Search And Seizure
- Sudarshan Pharma Industries Ltd Press Release Feb 22 2026
Later from Sudarshan Pharma Industries
- Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
- Sudarshan Pharma Industries Ltd Press Release May 08 2026
- Announcement under Regulation 30 (LODR)-Allotment
- Outcome Of Board Meeting Held Today I.E. Thursday, 21St May 2026
- Revision Of Disclosure Made By The Company Under Paragraph 2.1(F) Of The Master Circular Compliance With The Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 By Listed Entities.
Follow Sudarshan Pharma Industries into a list and get an email when it puts out news.
Follow Sudarshan Pharma Industries